Intradermal hepatitis B vaccination with imiquimod pretreatment in dialysis patients: a cost-effectiveness analysis
ID administration of HBV Sci-B-Vac with pre-treatment IMQ cream in serologically negative dialysis patients was the cost-effective strategy.
Authors
- Mingjun Rui (ORCID: https://orcid.org/0000-0001-8649-6454)
- Yingcheng Wang (ORCID: https://orcid.org/0000-0002-1784-4504)
- Joyce H. S. You (ORCID: https://orcid.org/0000-0002-5763-7403)
Institutions
- Chinese University of Hong Kong (HK)
Publication Details
- Journal
- Cost Effectiveness and Resource Allocation
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1186/s12962-025-00682-0
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00